The fund is constantly included in less than 2 deals per year. The top activity for fund was in 2018. Deals in the range of 50 - 100 millions dollars are the general things for fund.
Among the most popular portfolio startups of the fund, we may highlight AsclepiX Therapeutics, Poseida Therapeutics. Besides, a startup needs to be aged 6-10 years to get the investment from the fund. We can highlight the next thriving fund investment areas, such as Biotechnology, Genetics.
Besides them, we counted 1 critical employee of this fund in our database.
The usual cause for the fund is to invest in rounds with 7 partakers. Despite the Rapha Capital Management, startups are often financed by Malin Corporation, Vivo Capital, Tavistock Life Sciences. The meaningful sponsors for the fund in investment in the same round are Vivo Capital, TEDCO, Salem Partners.
Related Funds
Fund Name | Location |
Beijing Boyu Cangqiong Keji Youxian Gongsi | Beijing, Beijing, China |
Creation Venture Partners | Chaoyang, China, Liaoning |
D-Ax Corporate Venture Capital | Stockholm, Stockholm County, Sweden |
Dangdai Zhiye | China, Hong Kong, Hong Kong Island |
DFW Capital | New Jersey, Teaneck, United States |
Digital Irish Angels | New York, New York, United States |
Duquesne Family Office | - |
Euromate BV | Breda, Netherlands, North Brabant |
Hongxin Ziben | China, Fujian, Xiamen |
Legal & General Capital | England, London, United Kingdom |
Planet N Group of Companies | England, London, United Kingdom |
PTC Therapeutics | New Jersey, South Plainfield, United States |
Seentao Technology | Beijing, Beijing, China |
Stellar Internet GmbH | Germany, Hürth, Nordrhein-Westfalen |
The Blockchainer | China, Shanghai |
The Chainsmokers | New York, New York, United States |
Toyota Systems | Aichi Prefecture, Japan, Nagoya |
Venture Strategy Partners | California, San Francisco, United States |
Venturion Capital | Dedham, Massachusetts, United States |
Wire Accelerator | - |
Notable deals
Company | Industry | Round Size | Date | Investors | Location |
AsclepiX Therapeutics | $10M | 26 Jul 2023 | Baltimore, Maryland, United States | ||
Fize Medical | $5M | 06 Apr 2021 | Israel, Center District, Israel | ||
AsclepiX Therapeutics | $35M | 24 Jun 2020 | Baltimore, Maryland, United States | ||
Poseida Therapeutics | $142M | 22 Apr 2019 | San Diego, California, United States |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Latest deals
Company | Industry | Round Size | Date | Investors | Location |
AsclepiX Therapeutics | $10M | 26 Jul 2023 | Baltimore, Maryland, United States | ||
Fize Medical | $5M | 06 Apr 2021 | Israel, Center District, Israel | ||
AsclepiX Therapeutics | $35M | 24 Jun 2020 | Baltimore, Maryland, United States | ||
Poseida Therapeutics | $142M | 22 Apr 2019 | San Diego, California, United States |